top of page
Search

Autoimmune-Summaries: Daily Autoimmune Updates at a Glance

  • decodeMR Team
  • 20 minutes ago
  • 1 min read

18/08/2026








Biocon announced US FDA approval of Yesintek® single dose prefilled autoinjector (Ref)


Biocon announced that its US Subsidiary had received supplemental US FDA approval for Yesintek® (ustekinumab-kfce) as a single-dose prefilled autoinjector.


  • The approval covered 45 mg/0.5 mL and 90 mg/mL single-dose prefilled autoinjector presentations.


  • Yesintek® was approved for moderate-to-severe plaque psoriasis and active psoriatic arthritis in adult and pediatric patinets 6 years of age and for moderately-to-severely active Crohn’s disease and ulcerative colitis in adults.



bottom of page